Conclusion
A standard patient follow-up algorithm has not yet been determined for post-COVID-19 treatment. The necessity for follow-up of the symptoms of the disease that appear at the treatment and persist after the treatment should be demarcated. It is also important to differentiate to avoid the financial and sociological burden of post-treatment follow-up requirement. In this context, post-treatment follow-up algorithms should be determined. There is a need for specially designed comparative and evidence-based randomized clinical trials to determine a post-treatment follow-up algorithm for COVID-19 disease whose chronic effects have not yet been clarified.